<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPathology</journal-id><journal-title-group><journal-title>Open Journal of Pathology</journal-title></journal-title-group><issn pub-type="epub">2164-6775</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojpathology.2023.132010</article-id><article-id pub-id-type="publisher-id">OJPathology-123644</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Refractory Ascites Revealing an Ovarian Yolk Sac Tumor with Intraperitoneal Rupture
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vahatra</surname><given-names>Joëlle Razafimahefa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Herilalao</surname><given-names>Elisabeth Razafindrafara</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tojo</surname><given-names>Rémi Rafaralahivoavy</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tsitohery</surname><given-names>Francine Andriamampionona</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nantenaina</surname><given-names>Soa Randrianjafisamindrakotroka</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Department of Pathology, Medical School of Antananarivo, Antananarivo, Madagascar</addr-line></aff><aff id="aff3"><addr-line>Department of Radiology, CHU Andrainjato, Fianarantsoa, Madagascar</addr-line></aff><aff id="aff2"><addr-line>Department of Pathology, Soavinandriana Hospital Center Antananarivo, Antananarivo, Madagascar</addr-line></aff><aff id="aff1"><addr-line>Department of Pathology, CHU Andrainjato, Fianarantsoa, Madagascar</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>02</month><year>2023</year></pub-date><volume>13</volume><issue>02</issue><fpage>93</fpage><lpage>99</lpage><history><date date-type="received"><day>27,</day>	<month>December</month>	<year>2022</year></date><date date-type="rev-recd"><day>11,</day>	<month>March</month>	<year>2023</year>	</date><date date-type="accepted"><day>14,</day>	<month>March</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Yolk sac tumors of the ovary are rare entities that account for 2% - 5% of all ovarian tumors. They represent the second most common histological variant of malignant germ cell tumors of the ovary after dysgerminomas. Yolk sac tumors are most commonly encountered in women in the second and third decades. Microscopically, they are highly polymorphic and can present in a pure form or associated with another contingent of germ cell tumor. We report the case of a 26-year-old woman, who underwent surgery for a large right ovarian tumor rupturing into the peritoneal cavity. The ovarian tumor was revealed by ascites of great abundance and abdomino-pelvic pain. On histological examination, the diagnosis of yolk sac tumor in its pure and polyvesicular vitelline pattern was made. Through this observation, we propose to discuss the anatomoclinical particularities of these tumors by emphasizing the importance of histology for the diagnosis as well as the need of an early and appropriate management.
 
</p></abstract><kwd-group><kwd>Germ Cell Tumor</kwd><kwd> Yolk Sac Tumor</kwd><kwd> Ovary</kwd><kwd> Abdominal Distension</kwd><kwd> Schiller-Duval</kwd><kwd> Ascite</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Ovarian yolk sac tumors are defined as malignant ovarian germ cell tumors that account for only 2% - 5% of all ovarian tumors and less than 5% of all germ cell tumors [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] . They are mostly seen in adolescents and young women [<xref ref-type="bibr" rid="scirp.123644-ref2">2</xref>] .</p><p>Yolk sac tumors were initially discovered by Schiller in 1939, who suggested a mesonephroid origin. A few years later, Teilum reclassified these tumors and described their extraembryonal germ cell origin. He designated them as endodermal sinus tumors, which were termed later “Yolk sac tumor” due to their similarities with the extraembryonal yolk sac and vitelline structures [<xref ref-type="bibr" rid="scirp.123644-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref3">3</xref>] .</p><p>These tumors are rapidly growing and highly aggressive. Quality of diagnosis process and treatment implementation largely determines the prognosis [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref3">3</xref>] .</p><p>Herein, we report a case of ovarian yolk sac tumor with intraperitoneal rupture and refractory ascites.</p><p>Our purpose was to highlight through this case, the appropriate diagnostic and management procedures in order to improve the prognosis.</p></sec><sec id="s2"><title>2. Observation</title><p>A 26-year-old woman, nulliparous, with no other particular medical history, presented with abdomino-pelvic heaviness and pain, radiating to the right, evolving for 2 weeks and associated with an increased abdominal volume. On physical examination, the patient was in good general condition and subfebrile (37.8˚C). Abdominal distension and tenderness in the right iliac fossa have been noticed. The abdomino-pelvic ultrasound revealed an ovarian mass of heterogeneous components, measuring 19 cm along its long axis and associated with abundant peritoneal effusion (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The contralateral ovary was normal in appearance. AFP and CA-125 serum levels were elevated respectively to 19,206 ng/ml and 619 UI/l. The beta-hCG level as well as the rest of the laboratory testing was normal. The abdominopelvic CT scan showed a large abdominopelvic mass, originating from the right ovary, associated with diffuse and abundant intraperitoneal effusion (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The contralateral ovary and surrounding organs were normal. Neither adenopathy nor lesion suggestive of peritoneal carcinomatosis was objectified. An evacuating puncture was performed and 2.5 l of yellow citrine ascites were removed. Corresponding cytologic analysis demonstrated nonspecific cellular population, essentially composed of few macrophages and mesothelial cells without neoplastic cells. Due to the rapid recurrence of ascites and after a multidisciplinary meeting, a midline laparotomy with right adnexectomy was performed for anatomopathological examination. On macroscopic examination, the specimen showed a focally ruptured right ovarian tumor, measuring 19 &#215; 15 &#215; 6.5 cm with a smooth grayish—brown surface. Cut sections were heterogeneous with gelatinous, myxoid and necrotic—hemorrhagic areas. Cystic spaces with honeycomb patterns were also found (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Histopathological examination (<xref ref-type="fig" rid="fig4">Figure 4</xref>) demonstrated a neoplastic cell proliferation. Most of tumoral cells have clear cytoplasm and atypical nuclei with quite numerous mitotic figures and prominent nucleoli. They usually form anastomosing channels and are often arranged around vascular structures to form the pathognomonic Schiller-Duval bodies. Cystic cavities separated by fibrous stroma and lined by</p><p>flattened or cuboidal epithelium were also seen. The area of rupture was covered with a fibrous cap. Hemorrhagic and necrotic changes were found as well as myxoid areas. The fallopian tube appeared normal. Epiploic and peritoneal biopsies were also performed and did not demonstrate metastatic localization. The diagnosis of yolk sac tumor in its pure form with polyvesicular vitelline pattern was made. Immunohistochemical examination revealed strong expression of AFP antigen in tumor cells, confirming the diagnosis (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Postoperative outcomes were favorable with no evidence of recurrent ascites and a progressive decrease in the serum AFP level. The patient had received adjuvant chemotherapy with BEP (bleomycin, etoposide, cisplatin). Six months after the last chemotherapy course, serum AFP level was 5 ng/ml, abdominopelvic CT-scan was normal and the patient recuperated a regular menstrual cycle. Besides, chemotherapy related toxicity was not found and she has been free of recurrence for 2 years.</p></sec><sec id="s3"><title>3. Discussion</title><p>Yolk sac tumors of the ovary are rare tumors that usually occur in young women 20 - 30 years old [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref3">3</xref>] . They represent the second most common histologic subtype of malignant ovarian germ cell tumor after dysgerminomas [<xref ref-type="bibr" rid="scirp.123644-ref4">4</xref>] . These tumors are rapidly growing and clinical symptoms mainly include pelvic pain with an enlarging abdomino-pelvic mass [<xref ref-type="bibr" rid="scirp.123644-ref5">5</xref>] . They can also be revealed by ascites of variable abundance, secondary to torsion or intraperitoneal rupture [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] . Intraperitoneal rupture generally occurs in 30% of cases and can be pre- or intraoperative. In addition, associated peritonitis can also be observed, secondary to ascitic</p><p>fluid infection [<xref ref-type="bibr" rid="scirp.123644-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref7">7</xref>] . In our case, the patient presented with acute pelvic pain, abdomino-pelvic mass and refractory ascites of great abundance, due to tumor rupture. This tumor rupture, probably preoperative, was confirmed on macroscopic examination of the specimen. Imaging tests could not confirm or dismiss the diagnosis of Yolk sac tumor [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref2">2</xref>] . Ultrasound characterizes the adnexal mass and shows the presence of ascites or hepatic metastases. CT scan permits detection of peritoneal carcinomatosis or adenopathy [<xref ref-type="bibr" rid="scirp.123644-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref8">8</xref>] . MRI findings are often non-specific, characterized by hypervascular and hemorrhagic appearance [<xref ref-type="bibr" rid="scirp.123644-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref9">9</xref>] . For our patient, imaging examination have demonstrated an abdominopelvic tumor, of right ovarian origin, with heterogeneous contents, strongly suspicious of malignancy. Imaging also revealed the presence of ascites and the absence of peritoneal carcinomatosis or tumoral extension to adjacent organs. The diagnosis of yolk sac tumor is essentially based on histological examination [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] - [<xref ref-type="bibr" rid="scirp.123644-ref6">6</xref>] . Macroscopically, the ovarian mass is encapsulated and ranged in size from 3 to 30 cm. The tumor is usually round, oval or globular with smooth and glistening surface that may be firm or somewhat lobulated. Cut sections are solid and cystic with gelatinous changes and areas of hemorrhage and necrosis [<xref ref-type="bibr" rid="scirp.123644-ref10">10</xref>] . The existence of other germ cell tumors components could be sometimes grossly recognized, such as the presence of calcification which could suggest an associated mature teratoma [<xref ref-type="bibr" rid="scirp.123644-ref2">2</xref>] . In our case, gross appearance was typical of a pure yolk sac tumor. On histology, yolk sac tumors show great architectural polymorphism and varying histological subtypes. Three diagnostic criteria are often observed: reticular architecture with anastomosing channels, lined by tumor cells with clear cytoplasm and irregular, hyperchromatic, nucleolated nuclei with strong mitotic activity; Schiller–Duval bodies (pseudopapillary structures formed by tumor cells organized around vascular structures) and PAS-positive hyaline droplets [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] - [<xref ref-type="bibr" rid="scirp.123644-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref11">11</xref>] . In our case, the presence of cystic architecture, that appeared grossly as honeycomb areas was compatible with a polyvesicular vitelline pattern. The latter is often encountered in pure form of yolk sac tumor. On immunohistochemistry, yolk sac tumor is characterized by a constant expression of AFP by epithelial components [<xref ref-type="bibr" rid="scirp.123644-ref12">12</xref>] . However, other markers are useful for ruling out other tumors. Histologically, clear cell carcinoma constitutes the main differential diagnosis. This latter does not have Schiller-Duval bodies, can express AFP in rare cases and is positive for CK7 and EMA with diffuse staining. Yolk sac tumor is more polymorphic with negative staining for CK7 and EMA [<xref ref-type="bibr" rid="scirp.123644-ref2">2</xref>] . The distinction between these two tumors has a major interest in their therapeutic management. Unlike clear cell carcinoma, yolk sac tumor is very chemosensitive and in some cases, an evaluation of the postoperative chemotherapy response may be useful for diagnosis [<xref ref-type="bibr" rid="scirp.123644-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref13">13</xref>] . In our case, histological findings were typical of a yolk sac tumor with a strong expression of AFP by tumor cells, that facilitated the diagnosis. Besides, AFP serum level constitutes an important parameter for diagnosis and therapeutic surveillance. The decrease in its level may post-operatively reflect the absence of residual tumor [<xref ref-type="bibr" rid="scirp.123644-ref14">14</xref>] . Surgery followed by adjuvant chemotherapy constitutes the standard treatment for yolk sac tumor [<xref ref-type="bibr" rid="scirp.123644-ref6">6</xref>] . After chemotherapy, normalization of serum AFP level may be indicative of therapeutic efficacy. Serum AFP level is also more sensitive than CT for detecting tumor recurrences [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] - [<xref ref-type="bibr" rid="scirp.123644-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref14">14</xref>] . In our case, serum AFP level was extremely high preoperatively (19,206 ng/ml) and decrease gradually after surgery with a normal level (5 ng/ml) after chemotherapy.</p><p>For young patients wishing to preserve their fertility like in our case, surgical treatment consists in unilateral adnexectomy via laparotomy with peritoneal washing and complete staging procedure including peritoneal cytology as well as peritoneal and omental biopsies. Chemotherapy combines several molecules and represents a promising strategy to reduce the risk of recurrence [<xref ref-type="bibr" rid="scirp.123644-ref1">1</xref>] - [<xref ref-type="bibr" rid="scirp.123644-ref6">6</xref>] . In our case, the patient has benefited from a BEP-type protocol (bleomycin, etoposide, cisplatin). The VIP regimen (etoposide, ifosfamide, cisplatin) can also be used as a second-line treatment if the tumor persists [<xref ref-type="bibr" rid="scirp.123644-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.123644-ref15">15</xref>] . For our patient, clinical outcome was favorable, with no residual or recurrent tumor.</p></sec><sec id="s4"><title>4. Conclusion</title><p>Yolk sac tumors of the ovary are rare malignant germ cell tumors with a high potential for malignancy. They occur more often in young women. Serum AFP level and imaging examination can be helpful for diagnosis. The definitive diagnosis is based on histology. Conservative management might be proposed in young patients who wish to preserve their fertility. Given the very high chemosensitivity of yolk sac tumors, adjuvant chemotherapy clearly improves survival.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Razafimahefa, V.J., Razafindrafara, H.E., Rafaralahivoavy, T.R., Andriamampionona, T.F. and Randrianjafisamindrakotroka, N.S. (2023) Refractory Ascites Revealing an Ovarian Yolk Sac Tumor with Intraperitoneal Rupture. Open Journal of Pathology, 13, 93-99. https://doi.org/10.4236/ojpathology.2023.132010</p></sec></body><back><ref-list><title>References</title><ref id="scirp.123644-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Kehila, M., Skhiri, R., Boughizane, S., et al. (2009) Tumeur vitelline de l’ovaire révélée par une ascite de grande abondance. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 38, 516-520. https://doi.org/10.1016/j.jgyn.2009.04.010</mixed-citation></ref><ref id="scirp.123644-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Jabot, G., Koskas, M., Boyez, A., et al. (2013) Tumeur du sac vitellin rompue dans la cavité péritonéale. Imagerie de la Femme, 23, 176-180. https://doi.org/10.1016/j.femme.2013.06.001</mixed-citation></ref><ref id="scirp.123644-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Even, C., Lhommé, C., Duvillard, P., et al. (2011) Tumeurs du sac vitellin de l’ovaire: Revue de la littérature. Bulletin du Cancer, 98, 963-975. https://doi.org/10.1684/bdc.2011.1387</mixed-citation></ref><ref id="scirp.123644-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Smith, H.O., Berwick, M., et al. (2006) Incidence and Survival Rates for Female Malignant Germ Cell Tumors. Obstetrics &amp; Gynecology, 107, 1075-1085. https://doi.org/10.1097/01.AOG.0000216004.22588.ce</mixed-citation></ref><ref id="scirp.123644-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Chen, L.H., Yip, K.C., Wu, H.J. and Yong, S.B. (2019) Yolk Sac Tumor in an Eight-Year-Old Girl: A Case Report and Literature Review. Frontiers in Pediatrics, 7, 169. https://doi.org/10.3389/fped.2019.00169</mixed-citation></ref><ref id="scirp.123644-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Beurdeley, M., Gauthier, T., Piguet, C. and Fourcade, L. (2010) Conservative Treatment of Big Yolk Sac Tumour of the Ovary in Young Girl. Journal of Visceral Surgery, 147, e265-e267. https://doi.org/10.1016/j.jviscsurg.2010.08.007</mixed-citation></ref><ref id="scirp.123644-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">D&amp;#228;llenbach, P., Bonnefoi, H., Pelte, M.F. and Vlastos, G. (2006) Yolk Sac Tumours of the Ovary: An Update. European Journal of Surgical Oncology, 32, 1063-1075. https://doi.org/10.1016/j.ejso.2006.07.010</mixed-citation></ref><ref id="scirp.123644-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Yamaoka, T., Togashi, K., Koyama, T., et al. (2000) Yolk Sac Tumor of the Ovary: Radiologic-Pathologic Correlation in Four Cases. Journal of Computer Assisted Tomography, 24, 605-609. https://doi.org/10.1097/00004728-200007000-00017</mixed-citation></ref><ref id="scirp.123644-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Jung, S.E., Lee, J.M., Rha, S.E., Byun, J.Y., et al. (2002) Imaging of Ovarian Tumors with Emphasis on Differential Diagnosis. Radiographics, 22, 1305-1325. https://doi.org/10.1148/rg.226025033</mixed-citation></ref><ref id="scirp.123644-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Young, R.H., Wong, A. and Stall, J.N. (2022) Yolk Sac Tumor of the Ovary: A Report of 150 Cases and Review of the Literature. The American Journal of Surgical Pathology, 46, 309-325. https://doi.org/10.1097/PAS.0000000000001793</mixed-citation></ref><ref id="scirp.123644-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Young, R.H. (2014) The Yolk Sac Tumor: Reflections on a Remarkable Neoplasm and Two of the Many Intrigued by It—Gunnar Teilum and Aleksander Talerman—and the Bond It Formed between Them. International Journal of Surgical Pathology, 22, 677-687. https://doi.org/10.1177/1066896914558265</mixed-citation></ref><ref id="scirp.123644-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Rabban, J.T. and Zaloudek, C.J. (2013) A Practical Approach to Immunohistochemical Diagnosis of Ovarian Germ Cell Tumours and Sex Cord-Stromal Tumours. Histopathology, 62, 71-88. https://doi.org/10.1111/his.12052</mixed-citation></ref><ref id="scirp.123644-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Bahri, I., Boudawara, T., Khabir, A., Beyrouti, M.I., Frikha, M. and Jlidi, R. (2003) Carcinome à cellules claires de l’ovaire simulant une tumeur vitelline. Annales de Pathologie, 23, 165-168.</mixed-citation></ref><ref id="scirp.123644-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X., Ma, Z. and Li, Y. (2016) Ovarian Yolk Sac Tumor: The Experience of a Regional Cancer Center. International Journal of Gynecological Cancer, 26, 884-891. https://doi.org/10.1097/IGC.0000000000000704</mixed-citation></ref><ref id="scirp.123644-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Cicin, I., Saip, P., Guney, N., et al. (2009) Yolk Sac Tumours of the Ovary: Evaluation of Clinicopathological Features and Prognostic Factors. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology, 146, 210-214. https://doi.org/10.1016/j.ejogrb.2009.02.052</mixed-citation></ref></ref-list></back></article>